GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding GH Research PLC changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 35 | 32 | −3 |
| Shares | 29.6M | 29.6M | −2.90K (0.0%) |
| Value | $171.7M | $315.5M | +$143.8M (+83.8%) |
New holders (6)
Institutions that held GH Research PLC at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 87,938 | $937.4K | 0.01% |
| Corton Capital Inc. | 15,526 | $165.5K | 0.06% |
| ADAR1 Capital Management, LLC | 12,583 | $134.1K | 0.04% |
| Susquehanna International Group, LLP | 10,542 | $112.4K | 0.00% |
| Wells Fargo & Company | 1,250 | $13.3K | 0.00% |
| UBS Group AG | 209 | $2.23K | 0.00% |
Sold out (9)
Institutions that held GH Research PLC at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| VR Adviser, LLC | 1,318,327 | $7.65M |
| Deep Track Capital, LP | 499,400 | $2.90M |
| Mirae Asset Global Investments Co., Ltd. | 106,363 | $616.9K |
| Squarepoint Ops LLC | 41,279 | $239.4K |
| Two Sigma Investments, LP | 14,481 | $84.0K |
| State Street Corp | 10,704 | $62.1K |
| Northern Trust Corp | 10,138 | $58.8K |
| JPMorgan Chase & Co | 600 | $3.48K |
| Simplex Trading, LLC | 99 | $0 |